Windtree Therapeutics, Inc.
WINT
Rank in Stocks
#34408
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical firm... Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical firm primarily dedicated to developing therapies for acute cardiovascular ailments, and secondarily for acute pulmonary diseases. Its prominent therapeutic programs include istaroxime, undergoing Phase IIb clinical trials for acute decompensated heart failure and Phase IIa for early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant in Phase IIb for respiratory distress syndrome in preterm infants; Lyophilized KL4 surfactant, in Phase IIa trials for lung injury stemming from COVID-19; and Rostafuroxin, in Phase IIb for genetically associated hypertension. The company maintains collaborations, including one with Universita degli Studi di Milano-Bicocca for the discovery and advancement of novel SERCA2a compounds targeting chronic and acute human heart failure. It also holds a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and commercialization of a portfolio of potential KL4 surfactant products, and a collaboration with Battelle Memorial Institute to further develop its ADS for its Phase III program. Established in 1992 as Discovery Laboratories, Inc., the company rebranded as Windtree Therapeutics, Inc. in April 2016. It is headquartered in Warrington, Pennsylvania, and operates as a subsidiary of Lee's Pharmaceutical Holdings Limited.
Share Price
$0.0006
Last synced: 2026-11-09
Market Cap
$20.23K
Change (1 day)
0.00%
Change (1 year)
-99.25%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Windtree Therapeutics, Inc. (WINT)
Category
Healthcare
Operating Margin for Windtree Therapeutics, Inc. (WINT)
Operating Margin as of November 2026 TTM: 0.00%
According to Windtree Therapeutics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2024 the company had an operating margin of 0.00%.
Operating Margin history for Windtree Therapeutics, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | -12,572.22% | 1,288.03% |
| 2018 | -905.76% | -40.35% |
| 2017 | -1,518.38% | -18.48% |
| 2016 | -1,862.68% | -53.85% |
| 2015 | -4,035.87% | 164.50% |
| 2014 | -1,525.86% | -86.70% |
| 2013 | -11,471.13% | -40.85% |
| 2012 | -19,394.36% | 360.49% |
| 2011 | -4,211.68% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | -100.00% |
| 2008 | -834.65% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | -100.00% |
| 2005 | -44,250.00% | 1,062.20% |
| 2004 | -3,807.44% | 61.58% |
| 2003 | -2,356.32% | 132.98% |
| 2002 | -1,011.39% | -5.98% |
| 2001 | -1,075.72% | -33.00% |
| 2000 | -1,605.67% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Windtree Therapeutics, Inc.'s operating margin
What was Windtree Therapeutics, Inc.'s operating margin in 2024?
In 2024, Windtree Therapeutics, Inc.'s operating margin was 0.00%, compared with 0.00% in 2023.
How has Windtree Therapeutics, Inc.'s operating margin changed since 2019?
From 2019 to 2024, Windtree Therapeutics, Inc.'s operating margin was highest in 2024 (0.00%) and lowest in 2019 (-12,572.22%).
How does Windtree Therapeutics, Inc.'s operating margin compare with similar companies?
Windtree Therapeutics, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.